Showing results (481-490 of 537) with videos related to
Sort By:
Pageof 54
Biological Psychiatry|March 23, 2005
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in ratsWilliam A Carlezon, Michael L Rohan, Stephen D Mague, et al.Annals of Hematology|April 1, 2014
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)R Willemze, S Suciu, P Muus, et al.Letters in Applied Microbiology|March 28, 2013
The characterization of a thermostable and cambialistic superoxide dismutase from Thermus filiformisF Mandelli, J P L Franco Cairo, A P S Citadini, et al.Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.Blood|December 23, 1999
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemiaG Cimino, L Elia, M C Rapanotti, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?L Pagano, A Pulsoni, M E Tosti, et al.Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.Journal of Biological Regulators and Homeostatic Agents|April 23, 2014
Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgarisM L Roberti, L Ricottini, A Capponi, et al.British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.Pageof 54